Rhizopus Mix (Rhizopus stolonifer and Rhizopus oryzae)
**Product type:** Non-Standardized Allergenic
**Active ingredient:** RHIZOPUS ARRHIZUS; RHIZOPUS STOLONIFER
**Strength:** .0005; .0005 g/mL; g/mL
**Dosage form:** Solution
**Route:** Intradermal; Percutaneous; Subcutaneous
**Labeler:** Greer Laboratories, Inc.
**Marketing category:** BLA (BLA101833)
**Pharmacologic class:** Allergens [CS], Allergens [Chemical/Ingredient], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [Chemical/Ingredient], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]
/api/v1/systems/ndc_fda/nodes/22840-9668Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.